• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压治疗的经济学评估。

Economic evaluation of hypertension treatment.

作者信息

Johannesson M

机构信息

Stockholm School of Economics.

出版信息

Int J Technol Assess Health Care. 1992 Summer;8(3):506-23. doi: 10.1017/s0266462300013787.

DOI:10.1017/s0266462300013787
PMID:1399334
Abstract

A computer simulation model shows that the cost-effectiveness of treating hypertension is highly sensitive to different assumptions about the effectiveness of treatment, the outcome measure, the cost concept, the discounting of effects, and the duration of therapy. Cost-effectiveness analysis should be supplemented by another approach--cost-benefit analysis based on the contingent valuation (CV) method (the measurement, by survey, of willingness to pay). The CV method is tested in two empirical applications that indicate that it is possible to use the method in this area. Its results should be interpreted with caution, however, since the reliability and validity of the method is not yet established.

摘要

一个计算机模拟模型显示,治疗高血压的成本效益对有关治疗效果、结果指标、成本概念、效果贴现以及治疗持续时间的不同假设高度敏感。成本效益分析应以另一种方法——基于条件估值(CV)法(通过调查测量支付意愿)的成本效益分析作为补充。CV法在两个实证应用中得到了检验,这表明在该领域使用该方法是可行的。然而,其结果的解释应谨慎,因为该方法的可靠性和有效性尚未确立。

相似文献

1
Economic evaluation of hypertension treatment.高血压治疗的经济学评估。
Int J Technol Assess Health Care. 1992 Summer;8(3):506-23. doi: 10.1017/s0266462300013787.
2
Cost-effectiveness analysis of hypertension treatment--a review of methodological issues.高血压治疗的成本效益分析——方法学问题综述
Health Policy. 1991 Sep;19(1):55-77. doi: 10.1016/0168-8510(91)90074-8.
3
Willingness to pay for antihypertensive therapy--results of a Swedish pilot study.支付抗高血压治疗费用的意愿——一项瑞典试点研究的结果
J Health Econ. 1991;10(4):461-73. doi: 10.1016/0167-6296(91)90025-i.
4
Cost-effectiveness of hypertension treatment.
Clin Exp Hypertens. 1996 Apr-May;18(3-4):399-413. doi: 10.3109/10641969609088972.
5
The cost effectiveness of hypertension treatment in Sweden.瑞典高血压治疗的成本效益。
Pharmacoeconomics. 1995 Mar;7(3):242-50. doi: 10.2165/00019053-199507030-00008.
6
Cost-benefit of treating hypertension.
J Hypertens Suppl. 1994 Dec;12(10):S65-70.
7
Economic evaluation of osteoporosis prevention.骨质疏松症预防的经济学评估
Health Policy. 1993 May;24(2):103-24. doi: 10.1016/0168-8510(93)90029-o.
8
Cost-effectiveness issues in hypertension control.高血压控制中的成本效益问题。
Can J Public Health. 1994 Sep-Oct;85 Suppl 2:S54-6.
9
The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.绝对心血管风险、患者效用及成本对高血压治疗决策的影响:一项马尔可夫决策分析
J Hypertens. 2003 Sep;21(9):1753-9. doi: 10.1097/00004872-200309000-00026.
10
Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden.厄贝沙坦/氢氯噻嗪治疗高血压患者的成本效益:瑞典的一项经济学评估
J Hum Hypertens. 2008 Dec;22(12):845-55. doi: 10.1038/jhh.2008.76. Epub 2008 Jul 17.

引用本文的文献

1
Contingent Valuation Studies in Orthopaedic Surgery: A Health Economic Review.骨科手术中的意愿评估研究:一项卫生经济学综述。
HSS J. 2018 Oct;14(3):314-321. doi: 10.1007/s11420-018-9610-z. Epub 2018 Apr 9.
2
Willingness to pay as a measure of health benefits.将支付意愿作为衡量健康效益的指标。
Pharmacoeconomics. 1999 Jan;15(1):9-18. doi: 10.2165/00019053-199915010-00002.
3
Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.加拿大药品经济评估指南。加拿大药物经济学协作研讨会。
Pharmacoeconomics. 1996 Jun;9(6):535-59. doi: 10.2165/00019053-199609060-00008.
4
A review of cost-effectiveness analyses of hypertension treatment.高血压治疗的成本效益分析综述。
Pharmacoeconomics. 1992 Apr;1(4):250-64. doi: 10.2165/00019053-199201040-00003.
5
[Socioeconomic and quality of life repercussions of arterial hypertension].[动脉高血压对社会经济和生活质量的影响]
Drugs. 1998;56 Suppl 2:45-53. doi: 10.2165/00003495-199856002-00005.